Skip to main content
. 2016 Aug 11;11(8):e0160618. doi: 10.1371/journal.pone.0160618

Table 1. Summary of the Results Obtained with the Retrospective Analysis of the Three Pediatric Patient Groups.

  Conventional identification (2012) MALDI-ToF identification (2013) Rapid short incubation (2014)
Average age in months, (range) 17.9, (6.2–48.9) 18.9, (9–42.9) 23.1, (7.2–52.6)
Average comorbidities per patient, (range) 0.8, (0–2) 1.0, (0–5) 0.8, (0–4)
Male gender, number, (%) 25, (67.57) 26, (78.79) 10, (45.45)
Female gender, number, (%) 12, (32.43) 13, (21.21) 12, (54.55)
Average time to initiate antibiotics, (range) 14.5, (-2.65–34.71) 14.38, (-12.08–65.68) 9.12, (-0.57–24.65)
Average time to Gram stain result, (range) 29.62, (9.91–91.78) 27.29, (14.41–52.28) 25.21, (6.46–63.88)
Average time to initial identification, (range) 79.52, (23.95–140.85) 58.49, (24.85–213.31) 40.73, (14.55–154.27)
Average time to final identification, (range) 87.23, (23.95–146.81) 75.70, (28.18–213.31) 70.53, (14.55–154.27)
Average time to antibiotic change, (range) 78.33, (51.25–106) 68.76, (60.33–115.5) 58.13, (122.08–127.42)
Average length of hospital stay in days, (range) 23.81, (0.21–151.40) 21.71, (0.08–112.72) 12.28, (0.20–47.52)
Average LOS in correct empirical therapy group in days, (range) 20.79, (0.12–106.33) 22.15, (0.28–112.72) 13.04, (0.20–47.53)
Average LOS in antibiotic change group in days, (range) 44.40, (3.64–151.4) 20.75, (2.60–47.45) 10.94, (2.87–17.68)